The mechanism and risk factors of clopidogrel-induced liver injury.

about

Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells.

P2860

Q47335450-C0935DC2-48F3-446D-911C-7E4E97414DFC

P2860

The mechanism and risk factors of clopidogrel-induced liver injury.

Item

http://www.wikidata.org/entity/Q46625831

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

The mechanism and risk factors of clopidogrel-induced liver injury.

@en

The mechanism and risk factors of clopidogrel-induced liver injury.

@nl

type

Item

label

The mechanism and risk factors of clopidogrel-induced liver injury.

@en

The mechanism and risk factors of clopidogrel-induced liver injury.

@nl

prefLabel

The mechanism and risk factors of clopidogrel-induced liver injury.

@en

The mechanism and risk factors of clopidogrel-induced liver injury.

@nl

P1476

The mechanism and risk factors of clopidogrel-induced liver injury.

@en

P2093

Fan Yang

http://www.w3.org/2001/XMLSchema#string

Guo Feng

http://www.w3.org/2001/XMLSchema#string

Lijun An

http://www.w3.org/2001/XMLSchema#string

Lili Wang

http://www.w3.org/2001/XMLSchema#string

Shan Feng

http://www.w3.org/2001/XMLSchema#string

Tianyi Cui

http://www.w3.org/2001/XMLSchema#string

Xin He

http://www.w3.org/2001/XMLSchema#string

Yiran Zhai

http://www.w3.org/2001/XMLSchema#string

P2860

Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol

Preparation of isolated rat liver cells

Thiolactone sulfoxides as new reactive metabolites acting as bis-electrophiles: implication in clopidogrel and prasugrel bioactivation.

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

Idiosyncratic drug reactions: the reactive metabolite syndromes.

Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro.

Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.

Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature.

Platelet P2Y12 receptor inhibition by thienopyridines: status and future.

Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans.

P304

367-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/01480545.2015.1122606

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26654298

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

The mechanism and risk factors of clopidogrel-induced liver injury.

about

P2860

P2860

The mechanism and risk factors of clopidogrel-induced liver injury.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921